Growth Metrics

ProQR Therapeutics (PRQR) Free Cash Flow (2021 - 2025)

Historic Free Cash Flow for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to -$19.7 million.

  • ProQR Therapeutics' Free Cash Flow fell 52839.8% to -$19.7 million in Q4 2022 from the same period last year, while for Sep 2023 it was -$19.7 million, marking a year-over-year increase of 5984.94%. This contributed to the annual value of -$43.8 million for FY2024, which is 30078.42% down from last year.
  • Latest data reveals that ProQR Therapeutics reported Free Cash Flow of -$19.7 million as of Q4 2022, which was down 52839.8% from -$15.2 million recorded in Q3 2022.
  • In the past 5 years, ProQR Therapeutics' Free Cash Flow registered a high of $4.6 million during Q4 2021, and its lowest value of -$22.7 million during Q1 2022.